Lv1
8 积分 2026-03-12 加入
Site-specific engineering to produce CAR T cells in vivo
2个月前
已完结
A poorly reactogenic lipid nanoparticle-mRNA vaccine unveils an innate immune pathway for adverse reactions
2个月前
已完结
More than just a delivery system
2个月前
已完结
In vivo CAR T cell generation using retargeted and functionalized lentiviral vectors with reduced immunogenicity
2个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
3个月前
已关闭
Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy
3个月前
已完结
Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy
3个月前
已完结
Preparation of targeted lipid nanoparticles for precision nucleic acid delivery
3个月前
已完结
皖公网安备34019202002308
